Contributor Page
McDermott Will & Emery
Email  |  Website  |  Articles
Contact Details
Tel: +1 202 7568000
Fax: +1 202 7568087
The McDermott Building
500 North Capitol Street, N.W.
Washington, DC
United States
By Stephen Kranz, Diann Smith, Eric Carstens
Most states are well off to the races with their 2017 legislative sessions and several states have gift card legislation pending that would impact unclaimed property holders.
By Rebecca C. Martin, Laura McLane
On January 19, 2017, another district court ruled that a mere difference of opinion between physicians is not enough to establish falsity under the False Claims Act.
By Evan Belosa, Steven Eckhaus
The federal government's focus on pay equity and pay data, and the passage of groundbreaking equal pay laws in a number of states, has been one of the biggest employment law developments of 2016.
By Joan-Elisse Carpentier
Over the past week, President Donald J. Trump signed three Executive Orders involving US immigration issues.
By Carla Hine, Jon B. Dubrow
The Federal Trade Commission (FTC) and Antitrust Division of the Department of Justice (DOJ) announced several antitrust enforcement actions in advance of the inauguration of President Trump...
By Madeline Chiampou, Heather Cooper, Philip Tingle, Bradford LaBonte
On January 19, 2017, the Internal Revenue Service (IRS) issued Rev. Proc. 2017-19, 2016-6 I.R.B. (the Rev. Proc.), providing a safe harbor under which it will not challenge the tax treatment of an ESPC ESA...
By Joan-Elisse Carpentier
President Trump's January 27, 2017, Executive Order on US immigration has immediate ramifications for millions of legal immigrants, nonimmigrants and US businesses.
By Jacques Buhart, David Henry, Mark Bentley
It is difficult for General Counsel and their teams to monitor all new developments adequately.
By Mary Samsa, Jeffrey M. Holdvogt
Each of these issues present risks and opportunities for health systems in 2017.
By Michael Peregrine, Eric Zimmerman
With health care at the top of the new administration's to-do list, one thing is certain: change is afoot.
By Sarah Columbia
Though politics ruled the headlines in 2016, the year still brought big changes in intellectual property law and its application, most notably in patent subject matter eligibility, inter partes review institution and appeal and design patent damages.
By Laura McLane
On January 26, 2017, the US District Court for the Western District of Virginia rejected a defendant's attempt to invoke collateral estoppel principles to dismiss an indictment for fraud.
By Vernessa Pollard, Veleka Peeples-Dyer, Michael Ryan, Vanessa Burrows, Anisa Mohanty
The 21st Century Cures Act includes portions of five previously introduced bills that were not advanced by the Senate relating to FDA regulation of drugs, biologics and combination products, including:
By Veleka Peeples-Dyer, Vernessa Pollard, Michael Ryan, Vanessa Burrows, Shelby Buettner
Title III of the 21st Century Cures Act includes portions of the FDA Device Accountability Act of 2015, Promoting Biomedical Research and Public Health for Patients Act, and FDA and NIH Workforce Authorities Modernization Act.
By Mary Strimel, Stefan Meisner, Ashley McMahon
This month, the US Department of Justice Antitrust Division revised its "Frequently Asked Questions About the Antitrust Division's Leniency Program and Model Leniency Letters" (FAQs)...
Contributor's Topics